NO2636579T3 - - Google Patents
Info
- Publication number
- NO2636579T3 NO2636579T3 NO13157611A NO13157611A NO2636579T3 NO 2636579 T3 NO2636579 T3 NO 2636579T3 NO 13157611 A NO13157611 A NO 13157611A NO 13157611 A NO13157611 A NO 13157611A NO 2636579 T3 NO2636579 T3 NO 2636579T3
- Authority
- NO
- Norway
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Photosensitive Polymer And Photoresist Processing (AREA)
- Thermistors And Varistors (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161478059P | 2011-04-22 | 2011-04-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2636579T3 true NO2636579T3 (no) | 2018-07-21 |
Family
ID=47021791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO13157611A NO2636579T3 (no) | 2011-04-22 | 2013-03-04 |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US8592469B2 (no) |
| EP (1) | EP2699580B1 (no) |
| JP (1) | JP6045083B2 (no) |
| KR (1) | KR101839642B1 (no) |
| CN (1) | CN103582645B (no) |
| AU (1) | AU2012245702B2 (no) |
| BR (1) | BR112013027089A2 (no) |
| CA (1) | CA2833956C (no) |
| DK (1) | DK2699580T3 (no) |
| ES (1) | ES2652444T3 (no) |
| HR (1) | HRP20171930T1 (no) |
| HU (1) | HUE037730T2 (no) |
| IL (1) | IL228985A (no) |
| LT (1) | LT2699580T (no) |
| MX (1) | MX351961B (no) |
| NO (1) | NO2636579T3 (no) |
| PL (1) | PL2699580T3 (no) |
| PT (1) | PT2699580T (no) |
| RU (1) | RU2608308C2 (no) |
| SG (1) | SG194223A1 (no) |
| SI (1) | SI2699580T1 (no) |
| WO (1) | WO2012145255A2 (no) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3164897A1 (en) | 2019-12-23 | 2021-07-01 | Latvian Institute Of Organic Synthesis | Structurally simplified diazonamide analogs as antimitotic agents |
| WO2025114775A1 (en) * | 2023-11-29 | 2025-06-05 | Latvian Institute Of Organic Synthesis | Macrocyclic tubulin polymerization inhibitors as anticancer agents |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4261989A (en) | 1979-02-19 | 1981-04-14 | Kaken Chemical Co. Ltd. | Geldanamycin derivatives and antitumor drug |
| US5387584A (en) | 1993-04-07 | 1995-02-07 | Pfizer Inc. | Bicyclic ansamycins |
| US5932566A (en) | 1994-06-16 | 1999-08-03 | Pfizer Inc. | Ansamycin derivatives as antioncogene and anticancer agents |
| US5624677A (en) | 1995-06-13 | 1997-04-29 | Pentech Pharmaceuticals, Inc. | Controlled release of drugs delivered by sublingual or buccal administration |
| EP1289989A2 (en) | 2000-06-07 | 2003-03-12 | Lilly Icos LLC | Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
| AU2877102A (en) | 2000-11-02 | 2002-05-15 | Sloan Kettering Inst Cancer | Small molecule compositions for binding to hsp90 |
| US7517895B2 (en) * | 2001-08-24 | 2009-04-14 | Board Of Regents, The University Of Texas System | Synthetic diazonamides |
| US7022720B2 (en) | 2001-08-24 | 2006-04-04 | Board Of Regents, The University Of Texas System | Synthetic diazonamides as novel anti-mitotic agents |
| JP2007505933A (ja) | 2003-09-18 | 2007-03-15 | コンフォーマ・セラピューティクス・コーポレイション | Ｈｓｐ９０インヒビターとしての新規なヘテロ環化合物 |
| JP2009513710A (ja) * | 2005-10-31 | 2009-04-02 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | ジアゾンアミドａ類似体 |
| WO2008154441A1 (en) * | 2007-06-07 | 2008-12-18 | Joyant Pharmaceuticals, Inc. | Methods for preparing diazonamides |
| EP2268146B1 (en) | 2008-04-29 | 2015-08-26 | Joyant Pharmaceuticals, Inc. | Indoline anti-cancer agents |
| US8153619B2 (en) * | 2008-05-22 | 2012-04-10 | Joyant Pharmaceuticals, Inc. | Diazonamide analogs |
-
2012
- 2012-04-15 HU HUE12774761A patent/HUE037730T2/hu unknown
- 2012-04-15 CN CN201280025812.0A patent/CN103582645B/zh not_active Expired - Fee Related
- 2012-04-15 WO PCT/US2012/033715 patent/WO2012145255A2/en active Application Filing
- 2012-04-15 KR KR1020137030833A patent/KR101839642B1/ko not_active Expired - Fee Related
- 2012-04-15 US US13/447,259 patent/US8592469B2/en not_active Expired - Fee Related
- 2012-04-15 RU RU2013148153A patent/RU2608308C2/ru not_active IP Right Cessation
- 2012-04-15 DK DK12774761.6T patent/DK2699580T3/en active
- 2012-04-15 PL PL12774761T patent/PL2699580T3/pl unknown
- 2012-04-15 AU AU2012245702A patent/AU2012245702B2/en not_active Ceased
- 2012-04-15 CA CA2833956A patent/CA2833956C/en not_active Expired - Fee Related
- 2012-04-15 SI SI201231154T patent/SI2699580T1/en unknown
- 2012-04-15 MX MX2013012283A patent/MX351961B/es active IP Right Grant
- 2012-04-15 EP EP12774761.6A patent/EP2699580B1/en active Active
- 2012-04-15 JP JP2014506470A patent/JP6045083B2/ja not_active Expired - Fee Related
- 2012-04-15 LT LTEP12774761.6T patent/LT2699580T/lt unknown
- 2012-04-15 HR HRP20171930TT patent/HRP20171930T1/hr unknown
- 2012-04-15 PT PT127747616T patent/PT2699580T/pt unknown
- 2012-04-15 SG SG2013078308A patent/SG194223A1/en unknown
- 2012-04-15 ES ES12774761.6T patent/ES2652444T3/es active Active
- 2012-04-15 BR BR112013027089A patent/BR112013027089A2/pt not_active Application Discontinuation
-
2013
- 2013-03-04 NO NO13157611A patent/NO2636579T3/no unknown
- 2013-10-21 IL IL228985A patent/IL228985A/en active IP Right Grant
- 2013-11-25 US US14/089,655 patent/US8846734B2/en not_active Expired - Fee Related